[go: up one dir, main page]

CA2686885A1 - Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules - Google Patents

Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules Download PDF

Info

Publication number
CA2686885A1
CA2686885A1 CA002686885A CA2686885A CA2686885A1 CA 2686885 A1 CA2686885 A1 CA 2686885A1 CA 002686885 A CA002686885 A CA 002686885A CA 2686885 A CA2686885 A CA 2686885A CA 2686885 A1 CA2686885 A1 CA 2686885A1
Authority
CA
Canada
Prior art keywords
androgen
composition
ubidecarenone
extract
testosterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002686885A
Other languages
English (en)
Inventor
Ken Clement
Shan Chaudhuri
Michele Molino
Philip Apong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Innovations and Formulations Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2686885A1 publication Critical patent/CA2686885A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002686885A 2007-05-10 2007-05-10 Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules Abandoned CA2686885A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2007/000835 WO2008138095A1 (fr) 2007-05-10 2007-05-10 Composition permettant de maintenir un potentiel de fixation d'androgène et de tout élément similaire à l'androgène dans des cellules

Publications (1)

Publication Number Publication Date
CA2686885A1 true CA2686885A1 (fr) 2008-11-20

Family

ID=40001617

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002686885A Abandoned CA2686885A1 (fr) 2007-05-10 2007-05-10 Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules

Country Status (4)

Country Link
EP (1) EP2152285A4 (fr)
AU (1) AU2007353300A1 (fr)
CA (1) CA2686885A1 (fr)
WO (1) WO2008138095A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103588745B (zh) * 2013-11-26 2015-10-28 陕西嘉禾植物化工有限责任公司 一种从毛喉鞘蕊花中提取和分离弗斯可林的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6482596A (en) * 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
AU2004257756A1 (en) * 2003-07-10 2005-01-27 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements

Also Published As

Publication number Publication date
EP2152285A1 (fr) 2010-02-17
WO2008138095A1 (fr) 2008-11-20
AU2007353300A1 (en) 2008-11-20
EP2152285A4 (fr) 2010-11-17

Similar Documents

Publication Publication Date Title
US8491943B2 (en) Method and composition for improved anabolism
US20210220422A1 (en) Dietary supplement compositions and methods
JP6978392B2 (ja) トコトリエノールの経粘膜送達
US20080317886A1 (en) Compositions for Preventing and Reducing Delayed Onset Muscle Soreness
Kim et al. Comparison of the antiobesity effects of the protopanaxadiol‐and protopanaxatriol‐type saponins of red ginseng
US8062679B2 (en) Composition for maintaining androgen and androgen-like uptake potential by cells
US20070104805A1 (en) Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
CN101720225A (zh) 用于治疗缺血性心脏病、促进血液循环及血管发生、改善皮肤美观、以及改善男性性功能的含有人参果提取物的组合物
JP2007536250A (ja) 骨格筋におけるクレアチンの取り込みを増大するための栄養組成物
CN117715539A (zh) 骨骼肌营养组合物
EP3848025B9 (fr) Compositions comprenant des acides aminés destinés à être utilisés dans la prévention et le traitement des effets secondaires de la chimiothérapie
CN117915902A (zh) 营养组合物
CA2686885A1 (fr) Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules
WO2004062680A1 (fr) Proanthocyanidines permettant un bien-etre sexuel et la sante du systeme vasculaire sexuel
US20050069593A1 (en) Nutritional supplement containing 7-Keto-DHEA and conjugated linoleic acid
US20100189820A1 (en) Composition and Methods for Maintaining Skeletal Muscle Androgen Receptivity
SG188424A1 (en) Ingredients derived from sphaeranthus indicus
AU2004204527B2 (en) Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
FR2991181A1 (fr) Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique
KR102880689B1 (ko) 기억력 및 인지능력 개선용 영양제 조성물
KR100887388B1 (ko) 간 보호를 위한 건강보조식품
US20050171030A1 (en) Relieving symptoms of erectile dysfunction and attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
EA045710B1 (ru) Применение композиций, содержащих аминокислоты, для предотвращения и лечения кардиотоксичности, индуцированной химиотерапевтическими агентами
US20210346334A1 (en) Nutritional chromium compositions and methods of use
Farer Boosting testosterone naturally with TestoXLR8Pro™

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20150416